Pulmonary infections complicating hematological disorders

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 5, 2005, Pages 445-457

  Girmenia, Corrado ^a   Martino, Pietro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

"Hematopoietic stem cell transplant"; Leukemia; Neutropenia; Pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CASPOFUNGIN; CEFEPIME; CEFTAZIDIME; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; FOSCARNET; ISONIAZID; ITRACONAZOLE; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; RIFAMPICIN; STEROID; SULFAFURAZOLE; UNINDEXED DRUG; VORICONAZOLE;

ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALGORITHM; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIMICROBIAL THERAPY; BACTERIAL PNEUMONIA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EMPIRICISM; GRANULOCYTOPENIA; HEMATOLOGIC DISEASE; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; INFLAMMATION; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; LUNG INFILTRATE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; MOUTH ULCER; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POOR GENERAL CONDITION; PRIORITY JOURNAL; REVIEW; SEPTICEMIA; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VIRUS PNEUMONIA;

DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; STEM CELL TRANSPLANTATION;

EID: 27644523228     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-922029     Document Type: Review

References (41)

1. Tenholder MF, Hooper RG. Pulmonary infiltrates in leukemia. Chest 1980;78:468-473
2. Rubin RH, Greene R. Clinical approach to compromised host with fever and pulmonary infiltrates In: Rubin RH and Young LS, eds. Clinical Approach to Infection in the Compromised Host. 4th ed. New York: Kluwer Academic/Plenum; 2002:111-162
3. Horak DA. Pulmonary complications after hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. 3rd ed. 2004:873-882
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805
5. Poletti V, Trisolini R, Tura S. Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diff Lung Dis 2002;19:29-45
6. Morrison VA. The infectious complications of chronic lymphocytic leukemia. Semin Oncol 1998;25:98-106
7. Kontoyiannis DP, Ruoff K, Hooper DC. Nocardia bacteremia: report of 4 cases and review of the literature. Medicine 1998;77:255-267
8. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-917
9. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002;100:4358-4366
10. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-366
11. Pinto PS. The CT halo sign. Radiology 2004;230:109-110
12. Franquet T, Muller NL, Gimenez A, Guembe P, de La Torre J, Bague S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001;21:825-837
13. Sonnet S, Buitrago-Tellez CH, Tamm M, Christen S, Steinbrich W. Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients:preliminary results with high-resolution 16-MDCT angiography. AJR Am J Roentgenol 2005;185:746-751
14. Martino P, Girmenia C, Venditti M. Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia. Rev Infect Dis 1990;12:611-617
15. Gorelik O, Cohen N, Shpirer I, et al. Fatal haemoptysis induced by invasive pulmonary aspergillosis in patients with acute leukaemia during bone marrow and clinical remission: report of two cases and review of the literature. J Infect 2000;41:277-282
16. Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. Semiinvasive pulmonary aspergillosis. Radiology 1981;140:313-321
17. Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 2004;17:770-782
18. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498
19. Meijer E, Boland GJ, Verdonck LF. Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev 2003;16:647-657
20. Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 2001;27:877-881
21. Gentile G. Post-transplant HHV-6 Diseases. Herpes 2000;7:24-27
22. Couch RB, Englunf JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997;102(3A):2-9
23. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997;102(3A):10-18
24. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med 1997;102(3A):27-30
25. Ebbert JO, Limper AH. Respiratory syncytial virus pneumonitis in immunocompromised adults:clinical features and outcome. Respiration 2005;72:263-269
26. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997;102(3A):44-47
27. Marcolini JA, Malik S, Suki D, Whimbey E, Bodey GP. Respiratory disease due to parainfluenza virus in adult leucemia patients. Eur J Clin Microbiol Infect Dis 2003;22:79-84
28. Gentile G, Micozzi A, Girmenia C, et al. Pneumonia in allogenic and autologous bone marrow recipients: a retrospective study. Chest 1993;104:371-375
29. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003;102:827-833
30. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751
31. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002;94:3230-3246
32. Cornely OA, Ullmann AJ, Karthaus M. Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood 2003;101:3365-3372
33. Girmenia C, Martino P. New antifungal drugs and new clinical trials: interpreting results may be difficult. Curr Opin Oncol 2003;15:283-288
34. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415
35. Denning DW, Ribaud P, Milpied N. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-571
36. Aliff TB, Maslak PG, Jurcic JG. Refractory aspergillus pneumonia in patients with acute leukemia. Cancer 2003;97:1025-1032
37. Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004;39:1563-1571
38. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-637
39. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003;36:1445-1457
40. Centers for Disease Control and Prevention; Infectious Disease Society of America; American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stemcell transplant recipients. MMWR Recomm Rep 2000;49(RR-10):1-125 CE1-7
41. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. CDC: Healthcare Infection Control Practices Advisory Committee Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1-36